366 related articles for article (PubMed ID: 12206810)
1. Pharmacological control of cellular calcium handling in dystrophic skeletal muscle.
Ruegg UT; Nicolas-Métral V; Challet C; Bernard-Hélary K; Dorchies OM; Wagner S; Buetler TM
Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S155-61. PubMed ID: 12206810
[TBL] [Abstract][Full Text] [Related]
2. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
[TBL] [Abstract][Full Text] [Related]
3. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
4. Expression and localization of protein inhibitor of neuronal nitric oxide synthase in Duchenne muscular dystrophy.
Guo Y; Petrof BJ; Hussain SN
Muscle Nerve; 2001 Nov; 24(11):1468-75. PubMed ID: 11745948
[TBL] [Abstract][Full Text] [Related]
5. Direct observation of failing fibers in muscles of dystrophic mice provides mechanistic insight into muscular dystrophy.
Claflin DR; Brooks SV
Am J Physiol Cell Physiol; 2008 Feb; 294(2):C651-8. PubMed ID: 18171725
[TBL] [Abstract][Full Text] [Related]
6. Regulation of cytosolic calcium in skeletal muscle cells of the mdx mouse under conditions of stress.
Leijendekker WJ; Passaquin AC; Metzinger L; Rüegg UT
Br J Pharmacol; 1996 Jun; 118(3):611-6. PubMed ID: 8762085
[TBL] [Abstract][Full Text] [Related]
7. Is the normal content of sulfhydryl groups attributable to sparing from dystrophic pathology in dystrophin-deficient muscles?
Niebrój-Dobosz I; Fidziańska A; Glinka Z; Hausmanowa-Petrusewicz I
Folia Neuropathol; 2002; 40(3):143-50. PubMed ID: 12572920
[TBL] [Abstract][Full Text] [Related]
8. Taurine deficiency, synthesis and transport in the mdx mouse model for Duchenne Muscular Dystrophy.
Terrill JR; Grounds MD; Arthur PG
Int J Biochem Cell Biol; 2015 Sep; 66():141-8. PubMed ID: 26239309
[TBL] [Abstract][Full Text] [Related]
9. Expression profiling in stably regenerating skeletal muscle of dystrophin-deficient mdx mice.
Boer JM; de Meijer EJ; Mank EM; van Ommen GB; den Dunnen JT
Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S118-24. PubMed ID: 12206806
[TBL] [Abstract][Full Text] [Related]
10. How does dystrophin deficiency lead to muscle degeneration?--evidence from the mdx mouse.
McArdle A; Edwards RH; Jackson MJ
Neuromuscul Disord; 1995 Nov; 5(6):445-56. PubMed ID: 8580726
[TBL] [Abstract][Full Text] [Related]
11. Disodium cromoglycate protects dystrophin-deficient muscle fibers from leakiness.
Marques MJ; Ventura Machado R; Minatel E; Santo Neto H
Muscle Nerve; 2008 Jan; 37(1):61-7. PubMed ID: 17724738
[TBL] [Abstract][Full Text] [Related]
12. Creatine supplementation improves intracellular Ca2+ handling and survival in mdx skeletal muscle cells.
Pulido SM; Passaquin AC; Leijendekker WJ; Challet C; Wallimann T; Rüegg UT
FEBS Lett; 1998 Nov; 439(3):357-62. PubMed ID: 9845353
[TBL] [Abstract][Full Text] [Related]
13. Steroids in Duchenne muscular dystrophy: from clinical trials to genomic research.
Muntoni F; Fisher I; Morgan JE; Abraham D
Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S162-5. PubMed ID: 12206811
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Deflazacort Treatment on the Functioning of Skeletal Muscle Mitochondria in Duchenne Muscular Dystrophy.
Dubinin MV; Talanov EY; Tenkov KS; Starinets VS; Belosludtseva NV; Belosludtsev KN
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228255
[TBL] [Abstract][Full Text] [Related]
15. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
Burkin DJ; Wallace GQ; Nicol KJ; Kaufman DJ; Kaufman SJ
J Cell Biol; 2001 Mar; 152(6):1207-18. PubMed ID: 11257121
[TBL] [Abstract][Full Text] [Related]
16. Involvement of TRPC in the abnormal calcium influx observed in dystrophic (mdx) mouse skeletal muscle fibers.
Vandebrouck C; Martin D; Colson-Van Schoor M; Debaix H; Gailly P
J Cell Biol; 2002 Sep; 158(6):1089-96. PubMed ID: 12235126
[TBL] [Abstract][Full Text] [Related]
17. Myotubes from transgenic mdx mice expressing full-length dystrophin show normal calcium regulation.
Denetclaw WF; Hopf FW; Cox GA; Chamberlain JS; Steinhardt RA
Mol Biol Cell; 1994 Oct; 5(10):1159-67. PubMed ID: 7865881
[TBL] [Abstract][Full Text] [Related]
18. Microtubules underlie dysfunction in duchenne muscular dystrophy.
Khairallah RJ; Shi G; Sbrana F; Prosser BL; Borroto C; Mazaitis MJ; Hoffman EP; Mahurkar A; Sachs F; Sun Y; Chen YW; Raiteri R; Lederer WJ; Dorsey SG; Ward CW
Sci Signal; 2012 Aug; 5(236):ra56. PubMed ID: 22871609
[TBL] [Abstract][Full Text] [Related]
19. The proton pump inhibitor lansoprazole improves the skeletal phenotype in dystrophin deficient mdx mice.
Sali A; Many GM; Gordish-Dressman H; van der Meulen JH; Phadke A; Spurney CF; Cnaan A; Hoffman EP; Nagaraju K
PLoS One; 2013; 8(7):e66617. PubMed ID: 23843959
[TBL] [Abstract][Full Text] [Related]
20. Adenylosuccinic acid therapy ameliorates murine Duchenne Muscular Dystrophy.
Timpani CA; Goodman CA; Stathis CG; White JD; Mamchaoui K; Butler-Browne G; Gueven N; Hayes A; Rybalka E
Sci Rep; 2020 Jan; 10(1):1125. PubMed ID: 31980663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
